Sector Chart Atossa Therapeutics, Inc.

Stocks

ATOS

US04962H7044

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 28/08/2026 BST			5-day change	1st Jan Change
2.580 ^USD	-2.27%		+1.57%	-70.85%

08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ATOSSA THERAPEUTICS, INC.	25.75M	-	-	-	-	-
LONZA GROUP AG	50.47B
REVOLUTION MEDICINES, INC.	44.56B	-	-	-	-	-
IQVIA HOLDINGS INC.	43.08B
BEONE MEDICINES AG	41.7B
CELLTRION, INC.	33.21B